The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Proteomics Market Research Report 2025

Global Proteomics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1935457

No of Pages : 109

Synopsis

Proteomics is the study of the structure and functions of proteins that are used in drug discovery, diagnosis, and treatment of diseases. A proteome is never constant as it differs from one cell to other with time. Proteomics is used to evaluate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Structural proteomics is used to identify the structure of protein complexes, while functional proteomics is used for characterizing the protein‐protein interactions to demonstrate protein functions. In this report, the proteomics market is segmented by instrument, reagent, and services & software.

The global Proteomics market was valued at US$ 25770 million in 2023 and is anticipated to reach US$ 49020 million by 2030, witnessing a CAGR of 9.5% during the forecast period 2024-2030.

North American market for Proteomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Proteomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Proteomics in Clinical Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Proteomics include Thermo Fisher Scientific, Agilent, Merck KGaA, Danaher, Waters, Bio-Rad Laboratories, Bruker, GE Healthcare and PerkinElmer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Proteomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Proteomics.

Report Scope

The Proteomics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Proteomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Proteomics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List):

  • Thermo Fisher Scientific
  • Agilent
  • Merck KGaA
  • Danaher
  • Waters
  • Bio-Rad Laboratories
  • Bruker
  • GE Healthcare
  • PerkinElmer
  • Luminex
  • Creative Proteomics
  • Promega
  • LI-COR
  • HORIBA
  • Becton, Dickinson
  • Biognosys
  • Proteomics International
  • DC Biosciences
  • G-Biosciences
  • Bioproximity

Segment by Type

  • Proteomics Instruments
  • Proteomics Reagents
  • Proteomics Services
  • Proteomics Software

Segment by Application

  • Clinical Diagnostics
  • Drug Discovery
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Proteomics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Proteomics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Proteomics Instruments
1.2.3 Proteomics Reagents
1.2.4 Proteomics Services
1.2.5 Proteomics Software
1.3 Market by Application
1.3.1 Global Proteomics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Diagnostics
1.3.3 Drug Discovery
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Proteomics Market Perspective (2019-2030)
2.2 Proteomics Growth Trends by Region
2.2.1 Global Proteomics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Proteomics Historic Market Size by Region (2019-2024)
2.2.3 Proteomics Forecasted Market Size by Region (2025-2030)
2.3 Proteomics Market Dynamics
2.3.1 Proteomics Industry Trends
2.3.2 Proteomics Market Drivers
2.3.3 Proteomics Market Challenges
2.3.4 Proteomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Proteomics Players by Revenue
3.1.1 Global Top Proteomics Players by Revenue (2019-2024)
3.1.2 Global Proteomics Revenue Market Share by Players (2019-2024)
3.2 Global Proteomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Proteomics Revenue
3.4 Global Proteomics Market Concentration Ratio
3.4.1 Global Proteomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Proteomics Revenue in 2023
3.5 Proteomics Key Players Head office and Area Served
3.6 Key Players Proteomics Product Solution and Service
3.7 Date of Enter into Proteomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Proteomics Breakdown Data by Type
4.1 Global Proteomics Historic Market Size by Type (2019-2024)
4.2 Global Proteomics Forecasted Market Size by Type (2025-2030)
5 Proteomics Breakdown Data by Application
5.1 Global Proteomics Historic Market Size by Application (2019-2024)
5.2 Global Proteomics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Proteomics Market Size (2019-2030)
6.2 North America Proteomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Proteomics Market Size by Country (2019-2024)
6.4 North America Proteomics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Proteomics Market Size (2019-2030)
7.2 Europe Proteomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Proteomics Market Size by Country (2019-2024)
7.4 Europe Proteomics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Proteomics Market Size (2019-2030)
8.2 Asia-Pacific Proteomics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Proteomics Market Size by Region (2019-2024)
8.4 Asia-Pacific Proteomics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Proteomics Market Size (2019-2030)
9.2 Latin America Proteomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Proteomics Market Size by Country (2019-2024)
9.4 Latin America Proteomics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Proteomics Market Size (2019-2030)
10.2 Middle East & Africa Proteomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Proteomics Market Size by Country (2019-2024)
10.4 Middle East & Africa Proteomics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Proteomics Introduction
11.1.4 Thermo Fisher Scientific Revenue in Proteomics Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Agilent
11.2.1 Agilent Company Detail
11.2.2 Agilent Business Overview
11.2.3 Agilent Proteomics Introduction
11.2.4 Agilent Revenue in Proteomics Business (2019-2024)
11.2.5 Agilent Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Proteomics Introduction
11.3.4 Merck KGaA Revenue in Proteomics Business (2019-2024)
11.3.5 Merck KGaA Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher Proteomics Introduction
11.4.4 Danaher Revenue in Proteomics Business (2019-2024)
11.4.5 Danaher Recent Development
11.5 Waters
11.5.1 Waters Company Detail
11.5.2 Waters Business Overview
11.5.3 Waters Proteomics Introduction
11.5.4 Waters Revenue in Proteomics Business (2019-2024)
11.5.5 Waters Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Detail
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Proteomics Introduction
11.6.4 Bio-Rad Laboratories Revenue in Proteomics Business (2019-2024)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Bruker
11.7.1 Bruker Company Detail
11.7.2 Bruker Business Overview
11.7.3 Bruker Proteomics Introduction
11.7.4 Bruker Revenue in Proteomics Business (2019-2024)
11.7.5 Bruker Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Detail
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Proteomics Introduction
11.8.4 GE Healthcare Revenue in Proteomics Business (2019-2024)
11.8.5 GE Healthcare Recent Development
11.9 PerkinElmer
11.9.1 PerkinElmer Company Detail
11.9.2 PerkinElmer Business Overview
11.9.3 PerkinElmer Proteomics Introduction
11.9.4 PerkinElmer Revenue in Proteomics Business (2019-2024)
11.9.5 PerkinElmer Recent Development
11.10 Luminex
11.10.1 Luminex Company Detail
11.10.2 Luminex Business Overview
11.10.3 Luminex Proteomics Introduction
11.10.4 Luminex Revenue in Proteomics Business (2019-2024)
11.10.5 Luminex Recent Development
11.11 Creative Proteomics
11.11.1 Creative Proteomics Company Detail
11.11.2 Creative Proteomics Business Overview
11.11.3 Creative Proteomics Proteomics Introduction
11.11.4 Creative Proteomics Revenue in Proteomics Business (2019-2024)
11.11.5 Creative Proteomics Recent Development
11.12 Promega
11.12.1 Promega Company Detail
11.12.2 Promega Business Overview
11.12.3 Promega Proteomics Introduction
11.12.4 Promega Revenue in Proteomics Business (2019-2024)
11.12.5 Promega Recent Development
11.13 LI-COR
11.13.1 LI-COR Company Detail
11.13.2 LI-COR Business Overview
11.13.3 LI-COR Proteomics Introduction
11.13.4 LI-COR Revenue in Proteomics Business (2019-2024)
11.13.5 LI-COR Recent Development
11.14 HORIBA
11.14.1 HORIBA Company Detail
11.14.2 HORIBA Business Overview
11.14.3 HORIBA Proteomics Introduction
11.14.4 HORIBA Revenue in Proteomics Business (2019-2024)
11.14.5 HORIBA Recent Development
11.15 Becton, Dickinson
11.15.1 Becton, Dickinson Company Detail
11.15.2 Becton, Dickinson Business Overview
11.15.3 Becton, Dickinson Proteomics Introduction
11.15.4 Becton, Dickinson Revenue in Proteomics Business (2019-2024)
11.15.5 Becton, Dickinson Recent Development
11.16 Biognosys
11.16.1 Biognosys Company Detail
11.16.2 Biognosys Business Overview
11.16.3 Biognosys Proteomics Introduction
11.16.4 Biognosys Revenue in Proteomics Business (2019-2024)
11.16.5 Biognosys Recent Development
11.17 Proteomics International
11.17.1 Proteomics International Company Detail
11.17.2 Proteomics International Business Overview
11.17.3 Proteomics International Proteomics Introduction
11.17.4 Proteomics International Revenue in Proteomics Business (2019-2024)
11.17.5 Proteomics International Recent Development
11.18 DC Biosciences
11.18.1 DC Biosciences Company Detail
11.18.2 DC Biosciences Business Overview
11.18.3 DC Biosciences Proteomics Introduction
11.18.4 DC Biosciences Revenue in Proteomics Business (2019-2024)
11.18.5 DC Biosciences Recent Development
11.19 G-Biosciences
11.19.1 G-Biosciences Company Detail
11.19.2 G-Biosciences Business Overview
11.19.3 G-Biosciences Proteomics Introduction
11.19.4 G-Biosciences Revenue in Proteomics Business (2019-2024)
11.19.5 G-Biosciences Recent Development
11.20 Bioproximity
11.20.1 Bioproximity Company Detail
11.20.2 Bioproximity Business Overview
11.20.3 Bioproximity Proteomics Introduction
11.20.4 Bioproximity Revenue in Proteomics Business (2019-2024)
11.20.5 Bioproximity Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Proteomics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Proteomics Instruments
Table 3. Key Players of Proteomics Reagents
Table 4. Key Players of Proteomics Services
Table 5. Key Players of Proteomics Software
Table 6. Global Proteomics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Proteomics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Proteomics Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Proteomics Market Share by Region (2019-2024)
Table 10. Global Proteomics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Proteomics Market Share by Region (2025-2030)
Table 12. Proteomics Market Trends
Table 13. Proteomics Market Drivers
Table 14. Proteomics Market Challenges
Table 15. Proteomics Market Restraints
Table 16. Global Proteomics Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Proteomics Market Share by Players (2019-2024)
Table 18. Global Top Proteomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proteomics as of 2023)
Table 19. Ranking of Global Top Proteomics Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Proteomics Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Proteomics Product Solution and Service
Table 23. Date of Enter into Proteomics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Proteomics Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Proteomics Revenue Market Share by Type (2019-2024)
Table 27. Global Proteomics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Proteomics Revenue Market Share by Type (2025-2030)
Table 29. Global Proteomics Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Proteomics Revenue Market Share by Application (2019-2024)
Table 31. Global Proteomics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Proteomics Revenue Market Share by Application (2025-2030)
Table 33. North America Proteomics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Proteomics Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Proteomics Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Proteomics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Proteomics Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Proteomics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Proteomics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Proteomics Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Proteomics Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Proteomics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Proteomics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Proteomics Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Proteomics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Proteomics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Proteomics Market Size by Country (2025-2030) & (US$ Million)
Table 48. Thermo Fisher Scientific Company Detail
Table 49. Thermo Fisher Scientific Business Overview
Table 50. Thermo Fisher Scientific Proteomics Product
Table 51. Thermo Fisher Scientific Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 52. Thermo Fisher Scientific Recent Development
Table 53. Agilent Company Detail
Table 54. Agilent Business Overview
Table 55. Agilent Proteomics Product
Table 56. Agilent Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 57. Agilent Recent Development
Table 58. Merck KGaA Company Detail
Table 59. Merck KGaA Business Overview
Table 60. Merck KGaA Proteomics Product
Table 61. Merck KGaA Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 62. Merck KGaA Recent Development
Table 63. Danaher Company Detail
Table 64. Danaher Business Overview
Table 65. Danaher Proteomics Product
Table 66. Danaher Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 67. Danaher Recent Development
Table 68. Waters Company Detail
Table 69. Waters Business Overview
Table 70. Waters Proteomics Product
Table 71. Waters Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 72. Waters Recent Development
Table 73. Bio-Rad Laboratories Company Detail
Table 74. Bio-Rad Laboratories Business Overview
Table 75. Bio-Rad Laboratories Proteomics Product
Table 76. Bio-Rad Laboratories Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 77. Bio-Rad Laboratories Recent Development
Table 78. Bruker Company Detail
Table 79. Bruker Business Overview
Table 80. Bruker Proteomics Product
Table 81. Bruker Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 82. Bruker Recent Development
Table 83. GE Healthcare Company Detail
Table 84. GE Healthcare Business Overview
Table 85. GE Healthcare Proteomics Product
Table 86. GE Healthcare Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 87. GE Healthcare Recent Development
Table 88. PerkinElmer Company Detail
Table 89. PerkinElmer Business Overview
Table 90. PerkinElmer Proteomics Product
Table 91. PerkinElmer Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 92. PerkinElmer Recent Development
Table 93. Luminex Company Detail
Table 94. Luminex Business Overview
Table 95. Luminex Proteomics Product
Table 96. Luminex Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 97. Luminex Recent Development
Table 98. Creative Proteomics Company Detail
Table 99. Creative Proteomics Business Overview
Table 100. Creative Proteomics Proteomics Product
Table 101. Creative Proteomics Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 102. Creative Proteomics Recent Development
Table 103. Promega Company Detail
Table 104. Promega Business Overview
Table 105. Promega Proteomics Product
Table 106. Promega Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 107. Promega Recent Development
Table 108. LI-COR Company Detail
Table 109. LI-COR Business Overview
Table 110. LI-COR Proteomics Product
Table 111. LI-COR Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 112. LI-COR Recent Development
Table 113. HORIBA Company Detail
Table 114. HORIBA Business Overview
Table 115. HORIBA Proteomics Product
Table 116. HORIBA Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 117. HORIBA Recent Development
Table 118. Becton, Dickinson Company Detail
Table 119. Becton, Dickinson Business Overview
Table 120. Becton, Dickinson Proteomics Product
Table 121. Becton, Dickinson Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 122. Becton, Dickinson Recent Development
Table 123. Biognosys Company Detail
Table 124. Biognosys Business Overview
Table 125. Biognosys Proteomics Product
Table 126. Biognosys Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 127. Biognosys Recent Development
Table 128. Proteomics International Company Detail
Table 129. Proteomics International Business Overview
Table 130. Proteomics International Proteomics Product
Table 131. Proteomics International Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 132. Proteomics International Recent Development
Table 133. DC Biosciences Company Detail
Table 134. DC Biosciences Business Overview
Table 135. DC Biosciences Proteomics Product
Table 136. DC Biosciences Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 137. DC Biosciences Recent Development
Table 138. G-Biosciences Company Detail
Table 139. G-Biosciences Business Overview
Table 140. G-Biosciences Proteomics Product
Table 141. G-Biosciences Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 142. G-Biosciences Recent Development
Table 143. Bioproximity Company Detail
Table 144. Bioproximity Business Overview
Table 145. Bioproximity Proteomics Product
Table 146. Bioproximity Revenue in Proteomics Business (2019-2024) & (US$ Million)
Table 147. Bioproximity Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Proteomics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Proteomics Market Share by Type: 2023 VS 2030
Figure 3. Proteomics Instruments Features
Figure 4. Proteomics Reagents Features
Figure 5. Proteomics Services Features
Figure 6. Proteomics Software Features
Figure 7. Global Proteomics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Proteomics Market Share by Application: 2023 VS 2030
Figure 9. Clinical Diagnostics Case Studies
Figure 10. Drug Discovery Case Studies
Figure 11. Others Case Studies
Figure 12. Proteomics Report Years Considered
Figure 13. Global Proteomics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Proteomics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Proteomics Market Share by Region: 2023 VS 2030
Figure 16. Global Proteomics Market Share by Players in 2023
Figure 17. Global Top Proteomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proteomics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Proteomics Revenue in 2023
Figure 19. North America Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Proteomics Market Share by Country (2019-2030)
Figure 21. United States Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Proteomics Market Share by Country (2019-2030)
Figure 25. Germany Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Proteomics Market Share by Region (2019-2030)
Figure 33. China Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Proteomics Market Share by Country (2019-2030)
Figure 41. Mexico Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Proteomics Market Share by Country (2019-2030)
Figure 45. Turkey Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Proteomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 48. Agilent Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 49. Merck KGaA Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 50. Danaher Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 51. Waters Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 52. Bio-Rad Laboratories Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 53. Bruker Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 54. GE Healthcare Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 55. PerkinElmer Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 56. Luminex Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 57. Creative Proteomics Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 58. Promega Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 59. LI-COR Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 60. HORIBA Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 61. Becton, Dickinson Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 62. Biognosys Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 63. Proteomics International Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 64. DC Biosciences Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 65. G-Biosciences Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 66. Bioproximity Revenue Growth Rate in Proteomics Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’